to BioTechniques free email alert service to receive content updates.

protocol
Development and Optimization of Kinase Activity Assays using LANCEĀ® Ultra (TR-FRET) Reagents
Sponsored,vendor-submitted protocol   Sponsored by PerkinElmer    Published in BioTechniques Protocol Guide 2007 (p.47)

Protocol Abstract

Dysregulation of kinase activity plays a key role in many human diseases, making kinase inhibitors highly attractive drug candidates. PerkinElmer has a variety of luminescence, fluorescence and radioactive assay platforms for cell-based and biochemical kinase screening, profiling and validation. The selection of a kinase assay platform can depend upon the size of the kinase substrate, the throughput requirements, assay format, and the availability of a phospho-substrate antibody. PerkinElmer's LANCE® Ultra, with Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology, is ideally suited for ultra high-throughput kinase inhibitor screening and validation.

LANCE Ultra reagents include a series of europium chelate-labeled anti-phospho-substrate antibodies and several kinase peptide substrates directly labeled with the new proprietary dye, ULight™, which is a low molecular weight red-shifted dye. The direct labeling of the peptide substrate in combination with the use of the ULight dye, make LANCE Ultra TR-FRET assays highly efficient with less steric hindrance, with excellent Z’ values and prolonged assay stability when compared to traditional TR-FRET assays that utilize larger, less efficient dye combinations.


Figure 1. (Click to enlarge)


In this protocol we describe the development of a homogeneous kinase activity assay by monitoring the phosphorylation of the MBP peptide substrate by an ERK1 kinase. The MBP peptide is directly labeled with ULight, and the anti-phospho-MBP antibody is labeled with europium.


Figure 2. (Click to enlarge)


Protocol Summary:

  • Easy set up of a kinase activity assay utilizing highly efficient TR-FRET dyes: Europium and ULight

  • Assay is homogeneous and applicable for ultra high-throughput

  • The optimized assay developed using LANCE Ultra reagents shows robust performance suitable for HTS, as demonstrated by a Z’ value of 0.83.

  • Simplicity of use and minimal interference with screening compounds make LANCE Ultra the platform of choice for HTS kinase assays

More Information
 
Do you have question about this protocol? Would you like more information about this protocol?
Submit your questions here and Biotechniques will forward your question and contact information from our database to an expert at PerkinElmer who will contact you.
Yes, please forward my question, along with my name, title, company, and e-mail address to PerkinElmer
BioTechniques will forward your question to the company, who will contact you directly by email.
Request more information
 
Name Question
Job Title
Company
Email
Contact Information
Protocol Categories
rightcontent.jsp called otherwise condition rightcontent.jsp called 222222222222222222222
Search Protocols
Search our protocols for your specific technique.
Submit Your Protocols
BioTechniques is always looking for author-submitted protocols related to peer-reviewed papers, so submit your protocols today to our editorial team. Suppliers or advertisers interested in publishing their protocols should also submit.
Click here for more information